Estradiol undecylateEstradiol undecylate (EU or E2U), also known as estradiol undecanoate and formerly sold under the brand names Delestrec and Progynon Depot 100 among others, is an estrogen medication which has been used in the treatment of prostate cancer in men. It has also been used as a part of hormone therapy for transgender women. Although estradiol undecylate has been used in the past, it was discontinued and hence is no longer available. The medication has been given by injection into muscle usually once a month.
Estrogen esterAn estrogen ester is an ester of an estrogen, most typically of estradiol but also of other estrogens such as estrone, estriol, and even nonsteroidal estrogens like diethylstilbestrol. Esterification renders estradiol into a prodrug of estradiol with increased resistance to first-pass metabolism, slightly improving its oral bioavailability. In addition, estrogen esters have increased lipophilicity, which results in a longer duration when given by intramuscular or subcutaneous injection due to the formation of a long-lasting local depot in muscle and fat.
Cyproterone acetateCyproterone acetate (CPA), sold alone under the brand name Androcur or with ethinylestradiol under the brand names Diane or Diane-35 among others, is an antiandrogen and progestin medication used in the treatment of androgen-dependent conditions such as acne, excessive body hair growth, early puberty, and prostate cancer, as a component of feminizing hormone therapy for transgender women, and in birth control pills. It is formulated and used both alone and in combination with an estrogen.
Hormonosubstitution (dysphorie de genre)vignette|Seringue, parfois utilisée pour l'hormonosubstitution dans le cadre d'injections intramusculaires. L’hormonosubstitution, thérapie hormonale substitutive ou encore hormonothérapie est un traitement hormonal médical traitement médical destiné à entraîner une féminisation ou une masculinisation du corps d'une personne trans, en influençant l'aspect des caractères sexuels secondaires. Sa mise en place se fait généralement sous la surveillance d'un professionnel de santé.
Menstrual disorderA menstrual disorder is characterized as any abnormal condition with regards to a woman's menstrual cycle. There are many different types of menstrual disorders that vary with signs and symptoms, including pain during menstruation, heavy bleeding, or absence of menstruation. Normal variations can occur in menstrual patterns but generally menstrual disorders can also include periods that come sooner than 21 days apart, more than 3 months apart, or last more than 10 days in duration.
Estramustine phosphateEstramustine phosphate (EMP), also known as estradiol normustine phosphate and sold under the brand names Emcyt and Estracyt, is a dual estrogen and chemotherapy medication which is used in the treatment of prostate cancer in men. It is taken multiple times a day by mouth or by injection into a vein. Side effects of EMP include nausea, vomiting, gynecomastia, feminization, demasculinization, sexual dysfunction, blood clots, and cardiovascular complications.
Premarin (médicament)Le Premarin est un médicament à base d'œstrogènes conjugués, utilisé pour traiter les troubles de la ménopause chez la femme. Son nom vient de l'anglais pregnant mare urine désignant l'ingrédient principal, l'urine de jument gestante. Il a été mis sur le marché pour la première fois par l’entreprise Pfizer en 1941. D'autres médicaments utilisent des œstrogènes conjugués d'origine équine, comme le Premplus, commercialisé par le même entreprise, le Climopax et le Duavive.
ApalutamideL'apalutamide est une molécule de la classe des antiandrogènes non stéroïdiens, en cours de test dans le traitement du cancer de la prostate. Il se fixe de manière compétitive sur le récepteur des androgènes, inhibant son activité. Dans le cancer de la prostate évolutif malgré la castration, il retarde l'apparition de métastases ainsi que la progression des symptômes.
